160 related articles for article (PubMed ID: 38493416)
1. [Pharmacokinetic and pharmacodynamic considerations of antibiotic therapy among critically ill adult patients with sepsis].
Holub L; Szabó BG; Závorszky L; Hümpfner R; Andréka P; Karvaly GB; Lakatos B
Orv Hetil; 2024 Mar; 165(11):403-415. PubMed ID: 38493416
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic drug monitoring of beta-lactam antibiotics in critically ill adult patients].
Závorszky L; Rádler A; Galgóczi J; Tóth B; Csomós Á; Erőss A; Farkas R; Karvaly G; Holub L; Szabó BG; Lakatos B
Orv Hetil; 2023 Dec; 164(48):1904-1911. PubMed ID: 38043089
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic therapy in sepsis: No next time for a second chance!
Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients.
Sulaiman H; Roberts JA; Abdul-Aziz MH
Farm Hosp; 2022 Mar; 46(3):182-190. PubMed ID: 36183212
[TBL] [Abstract][Full Text] [Related]
5. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
[TBL] [Abstract][Full Text] [Related]
6. Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?
Dorofaeff T; Bandini RM; Lipman J; Ballot DE; Roberts JA; Parker SL
Clin Ther; 2016 Sep; 38(9):1961-75. PubMed ID: 27544661
[TBL] [Abstract][Full Text] [Related]
7. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
Landersdorfer CB; Nation RL
Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
10. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
Heffernan AJ; Sime FB; Taccone FS; Roberts JA
Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients.
Dhaese SAM; Roberts JA; Carlier M; Verstraete AG; Stove V; De Waele JJ
Int J Antimicrob Agents; 2018 Apr; 51(4):594-600. PubMed ID: 29277531
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic dosing in critically ill patients with acute kidney injury.
Eyler RF; Mueller BA;
Nat Rev Nephrol; 2011 Apr; 7(4):226-35. PubMed ID: 21343897
[TBL] [Abstract][Full Text] [Related]
13. Dose modulation: a new concept of antibiotic therapy in the critically ill patient?
Goncalves-Pereira J; Paiva JA
J Crit Care; 2013 Aug; 28(4):341-6. PubMed ID: 23337485
[TBL] [Abstract][Full Text] [Related]
14. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
[TBL] [Abstract][Full Text] [Related]
15. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice?
Scaglione F
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes.
Joynt GM; Ling L; Wong WT; Lipman J
Expert Rev Clin Pharmacol; 2023; 16(8):703-714. PubMed ID: 36942827
[TBL] [Abstract][Full Text] [Related]
17. A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients.
Carlier M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4689-94. PubMed ID: 26014946
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic dose optimization in critically ill patients.
Cotta MO; Roberts JA; Lipman J
Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii.
Jaruratanasirikul S; Wongpoowarak W; Wattanavijitkul T; Sukarnjanaset W; Samaeng M; Nawakitrangsan M; Ingviya N
Antimicrob Agents Chemother; 2016 Dec; 60(12):7236-7244. PubMed ID: 27671056
[TBL] [Abstract][Full Text] [Related]
20. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
